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Despite the high burden of tuberculosis (TB) worldwide, speciﬁc factors inﬂuencing disease transmission remain
elusive. Long term epidemiological studies and in vitro experimental models provide evidence of variable relative
ﬁtness of Mycobacterium tuberculosis (Mtb) strains but few such studies are available. Large sequence poly-
morphisms (LSP) are a robust molecular marker and are feasible as an epidemiological investigative tool. FewMtb
molecular epidemiological studies have been reported in Malawi owing to lack of laboratories with molecular
tools. We characterized the genetic diversity of Mtb clinical isolates amongst TB patients in Blantyre, Malawi. We
genotyped 64 Mtb clinical isolates using LSP-PCR, assigned speciﬁc lineages and conﬁrmed 18 of the isolates
using SMRT sequencing. The 64 isolates clustered into 4 lineages (L1-L4) with L4 predominating. There were 10/
64 (16%) isolates belonging to L1, 6/64 (9%) belonging to L2, 2/64 (3%) belonging to L3 and 46/64 (72%)
belonging to L4. Comparison with a previous study done in Karonga revealed concordance in L1 and L4 but
discodance in L2 and L3. The phylogenetic tree constructed, comprised of 3/4 lineages present in Blantyre with 3/
18 belonging to L1, 3/18 belonging to L2 and 12/18 belonging to L4. Four Mtb lineages were present in Blantyre
with L4 predominating. Larger studies are needed to understand the molecular epidemiology of TB in Blantyre in
light of increased bi-directional migration with South Africa.1. Introduction
Globally, there were 10 million new cases and 1.3 million deaths due
to tuberculosis (TB) with a further 0.4 million due to coinfection with
HIV in 2017 [1]. Africa remains the hardest hit in terms of rates of active
TB per capita [2, 3, 4] and the highest proportion of TB cases co-infected
with HIV are in Africa (31%) with Southern Africa bearing the greatest
burden (>50%) [5].
Malawi is a country in the South East of Africa with a population of
about 17.5 million [6] and 24.3% of the population living in severe
multi-dimensional poverty [7]. Malawi is among the top 20 high TB
burden countries with the highest estimated number of incident TB cases
among people living with HIV [4]. Concerning molecular epidemiologyovu).
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evier Ltd. This is an open accessof TB in Malawi, a few studies have been reported from the northern
region of the country under the Karonga Prevention Study (KPS) [8, 9]. A
lack of laboratories with molecular tools has hampered efforts to conduct
Mycobacterium tuberculosis (Mtb) molecular epidemiology studies in
Malawi and in most other low resource settings. Mtb molecular epide-
miological data for the rest of the country is lacking. The currently pre-
vailing Mtb lineages for the country remain to be established and
longitudinal transmission elucidated. Knowledge of changes in the pre-
dominant circulating Mtb strains in Blantyre may aid in understanding
the local TB epidemic and reﬁning TB control strategies.
In this study we use large sequence polymorphism (LSP) polymerase
chain reaction (PCR) to perform a preliminary characterization of the
genetic diversity of Mtb clinical isolates amongst patients presenting attober 2019
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referral hospital in the country. The samples were collected over an 18
months period (June 2010 to December 2011). We used Single Molecule
Real Time Sequencing (SMRT) to conﬁrm the phylogenetic lineages of a
representative 18 of these strains.
2. Materials and methods
2.1. Study setting and population
The study was conducted in Blantyre, the largest commercial city in
Malawi situated in the southern region of the country. The city has a
population of over 800,000 people according to the 2018 population and
housing census [6], and 65% of the city's population live in informal
settlements with poor living conditions [10].
The study was conducted as part of a larger study “Studying Persis-
tence and Understanding Tuberculosis in Malawi (S.P.U.T.U.M) for
which ethical approval had been obtained from the College of Medicine
Research Ethics Committee [11] This was a prospective cohort study of
persons with smear and culture positive pulmonary TB from Blantyre
Malawi. A total of 133 Mtb strains collected from patients presenting
with sputum smear positive TB at Queen Elizabeth Central Hospital
(QECH) during an 18-month period (June 2010–December 2011) and
used for strain typing. Both new and retreatment cases irrespective of
HIV status were enrolled and participants were aged 16–65 years. Only
64/133 Mtb strains were successfully revived from frozen state and
conﬁrmed as Mtb. Mtb was conﬁrmed using the BD MGIT TBC ID test
device (Becton Dickinson, Maryland U.S.A) and Ziehl Neelsen (ZN)
staining and culture on Lowenstein Jensen (LJ) slants following standard
laboratory procedures. Bacterial cultures were grown to mid-log phase
(6–8 weeks) before being harvested for DNA isolation.
2.2. Drug susceptibility testing
Determination of minimum inhibitory concentrations (MICs) of the
Mtb isolates was carried out using UKMYC3 sensititre custommade plates
(Thermo Scientiﬁc) following manufacturer's instructions. The plates
contained different concentrations of RIF (0.015–16 μg/mL), INH
(0.015–16 μg/mL) and EMB (0.25–16 μg/mL). Brieﬂy, a loopful of col-
onies were scraped from LJ slants and emulsiﬁed in a MacFarland tube
containing saline, 0.2% tween and glass beads. The tube was vortexed for
30 seconds and turbidity adjusted to 0.5 MacFarland standard. A100 μl
aliquot was transferred into a tube of 10ml of 7H9 broth supplemented
with 10% OADC to give an inoculum of ~1  105 CFU/mL. The sus-
pension was brieﬂy vortexed and a 100 μl aliquot transferred into each
well of the microtitre plate for inoculation. Wells were covered with
adhesive seal, wiped with 5% Surfanios and 70% ethanol before being
placed into a sealed plastic bag. Plates were incubated at 37 C for 10
days after which visual inspection of growth was done. Plates with poor
growth were re-checked using the positive control at days 14 and 21.
Plates were read when growth was clearly visible in the positive control.
2.3. DNA extraction and genotyping
Genomic DNA was isolated using a Cetyltrimethylammonium bro-
mide (CTAB) method as previously described [12]. Genotyping of iso-
lates was performed at the Liverpool School of Tropical Medicine, United
Kingdom. A singleplex PCR based method using speciﬁc primers speciﬁc
for each of regions of difference RD239 (L1), RD105 (L2) and RD 750
(L3) was employed. Primers were selected based on Mtb molecular
epidemiology studies in and around Malawi in the last 15 years [13, 14,
15, 16]. All isolates not falling within these three lineages were presumed
to be Lineage 4 (Euro-American) and a representative sample were
subsequently conﬁrmed by sequencing. PCR reactions were performed in
a micro centrifuge tube to a ﬁnal volume of 15 μL. For an RD239 reaction
mixture, to 15ng of DNA was added a PCR master-mix containing 1x2buffer (Bioline, UK), 0.2mM dNTPs, 0.5μM each primer (forward and
reverse),1.50mM MgCl2, double distilled water and Taq polymerase
(Bioline, UK). PCR reactions were performed at 95 C for one 3-minute
cycle, three 25 cycles of 30 seconds at 95 C, 64 C and 72 C respec-
tively and a 6-minute cycle at 72 C.
For the RD105 and RD 750 the reaction mixture contained 15ng of
DNA and a PCR master mix of 1x buffer without MgCl2 (EHF), 0.2mM
dNTPs, 1.5mMMgCl2, 0.3μM each primer (forward and reverse) and EHF
Taq polymerase. PCR reactions were performed at one 3-minute cycle at
95 C, 25 cycles of 95C/15 seconds, 64C/15 seconds, 72C/4 minutes
and 6 minutes at 72 C. Primers used were RD239 forward F50-GGC CAA
CAT CGA CCA CCT ACC C-30 and R50-ATC CTC GCT ACC GGC ACC TCA
T-3’. For RD105, F 50-GGAGTCGTT GAGGGTGTT CAT CAGCTC AGT C-
30 and R 50-CGC CAA GGC CGC ATA GTC ACG GTC G-30and for RD750,
F50- GTC AAC TGC CGA TGG CTG AC-30 and R 50- CGT CAG CGA TGA
TCA CCT CG-3’. PCR products were electrophoresed on 1% agarose,
stained with ethidium bromide before being visualized under UV light.
2.4. DNA sequencing and bioinformatics analysis
DNA was sequenced at the Centre for Genomic Research (CGR),
University of Liverpool, United Kingdom on Paciﬁc Biosciences RSII
sequencing system (Paciﬁc Biosciences, Menlo Park, CA, USA). Single
Molecule Real Time (SMRT) sequencing was used at 360-minute movie
times per cell, yielding ~174x average genome coverage. All the raw
SMRT sequencing data used in this paper have been submitted to the
European Nucleotide Archive (ENA) databases under accession no.
PRJEB28592 and is accessible at: http://www.ebi.ac.uk/ena/data/
view/PRJEB28592. Bioinformatics analysis was conducted using the
RS_Modiﬁcation_and_Motif_Analysis.1 protocol in SMRT Portal (version
2.2.0). Sequence reads were mapped using the Basic Local Alignment
with Successive Reﬁnement (BLASR) [17] algorithm within the SMRT
portal. A phylogenetic tree was constructed for the 18 sequences using
RAxML (Randomized Axelerated Maximum Likelihood) a program for
phylogenetic analysis in GTRCAT model [18] based on all polymorphic
sites. To analyze methylation patterns inMtb the reference ﬁle for H37Rv
(GenBank accession NC_000962) containing all genomic annotations in
general features format (gff) was downloaded. All rows in the genome
containing 6-methyladenine (m6A) modiﬁcations were extracted using a
custom script run in Python software.
The genomic ranges for the genes were obtained from ProteinTa-
ble166_159857.txt (http://www.ncbi.nlm.nih.gov/genome/protein
s/166?genome_assembly_id¼159857). If the gene was on the positive
strand, the start site was reduced by 100 nucleotides while if the gene
was on the negative strand, the start site was extended by 100 nucleo-
tides. Any m6A modiﬁcation found within the gene's genomic range was
reported.
3. Results
Sixty-four bacteriologically culture conﬁrmed Mtb positive samples
were selected based on the ﬁrst to be successfully revived from a total of
133 isolates and subjected to genomic deletion analysis. The analysis
revealed 6 (9%) East Asian lineage (L2) (RD 105 deleted) strains
generating a deleted product ~785bp on gel electrophoresis, 10 (16%)
(L1) Indo-oceanic lineage (RD 239 deleted) strains, 2 (3%) East African/
Indian lineage (L3) (RD750 deleted) strains and 46 (L4) (72%) Euro-
American lineage strains (Fig. 1). No mixed infection was detected as
no samples was found with two different deletions.
It was not possible to design lineage speciﬁc primers for the Euro-
American lineage, a common previously reported lineage in Malawi.
Twelve out of the 46 isolates were conﬁrmed as Euro-American using
whole genome sequencing. All other strains lacking deletions stated
above were assumed to belong to the Euro-American lineage owing to the
fact that this lineage was reported to be the most predominant in the
region and has previously been reported at a high prevalence in Karonga
Fig. 2. Phylogenetic analysis of the 18 sequenced Mycobacterium tuberculosis
strains from Blantyre Malawi.
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isolate was INH resistant and a single isolate was multi-drug resistant
(resistant to INH and RIF).
Proportions ofMtb lineages occurring in Blantyre; 46 (72%) lineage 4
(Euro-American), 10 (16%) Lineage 1(Indo-oceanic), 6 (9%) lineage 2
(Beijing), 2 (3%) lineage 3 (East African/Indian) and in Karonga
M. tuberculosis strains (68%) were lineage-4, with 16% lineage-1, 4%
lineage-2, and 12% lineage-3 Blantyre samples were collected between
June 2010 and December 2012 while Karonga samples were collected
between September 1995 and September 2010.
3.1. Whole genome sequence analysis
In this study 18/64 Mtb genomes were completed using SMRT
sequencing to compare and conﬁrm the results of genomic deletion
analysis in this subset of the strains. The average sequencing coverage
was ~x174 (range x35-460) with mean read length ~8kb (range
3.5–12kb) and N50 read length ~12kb (range 5–24kb). In comparison
with the Mtb H37Rv reference genome (NC_000962) [19] the 18 ge-
nomes showed >99.8% identity at the nucleotide level. Using phyloge-
netic analysis, a total of 14,353 SNPs were found in the non-repetitive
regions with one sample having 6,909 SNPs not present in any other
sample. The SNPs present in more than one sample (7444) were used to
construct a genome-wide maximum likelihood phylogenetic tree (Fig. 2)
which comprised of 3 of the 4 Mtb lineages known to be present in
Malawi (L1, L2 and L4). Three of the 18 strains belonged to lineage 1
(Indo-oceanic), 3/18 to lineage 2 (East-Asian) and 12/18 belonged to
lineage 4 (Euro-American). No lineage 3 strain was found among the 18
sequences. All lineage 4 Mtb strains have been reported to possess a 7 bp
deletion in the pks15/1 gene [20]. Screening for this deletion in the 18
strains conﬁrmed that 12/18 strains belonged to lineage 4. Additionally,
membership of lineages 1 and 2 was conﬁrmed by the presence of lineage
speciﬁc mutations causing loss of methyltransferase activity (C758T and
A809C respectively) as previously reported [21].
Strains clustered into 3 lineages (L1,2 and 4). Green indicates that
strains belong to lineage 1(Indo-oceanic), red indicates that strains
belong to lineage 2 (East Asian-Beijing) and blue indicates strains belong
to lineage 4 (Euro-American). M, canettii was used as an outlier and the
branch support values determined by 1000 bootstrap replicates.
4. Discussion
This is the ﬁrst description of Mtb genotypes circulating in Blantyre,
Malawi. Sixty-four out of one hundred and thirty-three clinical isolates
from patients presenting at a referral facility in Blantyre, Malawi were
genotyped using genomic deletion analysis and 18 of these compared
with classiﬁcation according to whole genome sequencing. Globally, 7
major lineages of Mtb have been deﬁned and 4 of these were detected as
circulating in Blantyre. The Euro-American lineage (lineage 4) is the most
predominant of the Mtb lineages in Europe and America but has speciﬁcFig. 1. Comparison of the diversity ofMycobacterium tuberculosis in Blantyre and
Karonga, Malawi.
3sub-lineages dominating in Africa [20, 22]. Results in this study and
those done previously in Malawi [8, 13] demonstrate complete concor-
dance with those done in this region of Africa [23]. In the present study,
lineage 4 was identiﬁed by default based on the absence of deletions RD
105, 239 and 750. The fact that no deletion analysis was done to conﬁrm
the number of isolates belonging to lineage 4 does not exclude the pos-
sibility that a novel lineage not previously reported in Malawi could be
present. In addition membership of lineage 4 can be conﬁrmed by the
presence of a short 7bp deletion (GCCGCGG) in the polyketide synthase
(pks 15/1) gene and a CTG to CGG substitution in katG gene at posi-
tion/codon 463 [20, 22, 24, 25]. Bioinformatics analysis of the 18
sequenced isolates in this study revealed the presence of this 7bp deletion
in only 12 of the 18 sequences further conﬁrming the ﬁndings from the
LSP assay. A small sample size not withstanding, our results are largely in
concordance with previous studies done in Karonga [8, 9]. In one
particular study, out of 781 patients with a ﬁrst episode of TB, 76% were
Euro-American lineage [8] while in another, the lineage was found to
occur at 68% [13]. The Euro-American lineage appears to be the pre-
dominant lineage in Malawi based on data from both studies although
more studies are necessary countrywide to deﬁnitively conﬁrm these
results and provide greater impact of this lineage on disease burden in
Malawi.
The presence of Lineage 1 (16%) detected using PCR in this study is
consistent with reports from Karonga [13]. Similarly, phylogenetic
analysis conﬁrmed that 3 of the isolates that were identiﬁed as lineage 1
(Indo-oceanic) using LSP-PCR were indeed of this lineage. Again, mem-
bership of this lineage could further be conﬁrmed by loss of a methyl-
transferase mamB attributed to a missense mutation in the Rv2024c gene
[26]. Although lineage 1 has global prevalence, it is more common in
East Africa and the Indian sub-continent [27]. Karonga is easily acces-
sible from the East African country of Tanzania which has a higher
prevalence of this lineage and so the expectation might have been that a
higher prevalence of this lineage would have been observed than in
Blantyre. However, a larger study would be needed to draw robust
conclusions regarding the prevalence and transmission of L1 throughout
Malawi as a whole.
The East Asian lineage (L2) which includes the Beijing genotype, has
been reported to be widespread globally and may be associated with
increasing drug resistance in some regions [28]. In Mozambique, which
is close to Blantyre, the modern Beijing genotype was associated with
increasing virulence compared to ancient strains [29] and also with HIV
V. Ndhlovu et al. Heliyon 5 (2019) e02638infection [16]. The results of the published data from Malawi differ in
that no association of any lineage with HIV could be established. The
phylogenetic tree constructed from SNPs and indels conﬁrmed that 3/18
isolates belonged to L2. Additionally, methylation analysis revealed that
these three samples lacked the mamAmethyltransferase owing to a point
mutation in the Rv3263c gene, which is characteristic of L2 clinical
isolates [30]. In Malawi the L2 has previously been reported from
approximately ~2% of patients and no association with drug resistance
has been reported [8]. All the L2 strains from the current study were drug
sensitive which is consistent with the study from Karonga [13]. An as-
sociation between East Asian lineage/Beijing genotype and drug resis-
tance is yet to be seen in Malawi, possibly because the overall prevalence
of drug resistance is low by regional standards and L2 remains relatively
rare to date. Future studies should investigate genotype-phenotype as-
sociations of the L2/Beijing genotype in Blantyre and Malawi as a whole.
The data from this Blantyre study provides an important baseline to track
future emergence of L2/Beijing genotype in southern Malawi and any
increased association with drug resistance as it emerges. The results
presented here may appear to suggest a higher prevalence of the L2
strains at 9% in Blantyre compared to 4% in Karonga [13]. However, it is
possible a higher prevalence of the L2 in Blantyre compared to Karonga
could be attributed to the fact that Blantyre is an urban setting where
transmission rates are likely to be higher. Furthermore Blantyre has a
higher geographical accessibility to South Africa and Mozambique where
the L2/Beijing genotype has been reported at a higher prevalence [16, 31].
A study of strains from histological samples from a 76-year period in
South Africa demonstrated that the Beijing strain was a recent arrival in the
country [14]. It would be reasonable to infer that a similar trend could
occur in Malawi as there is a high level of regional migration between
Malawi and South Africa. A study from Karonga suggests that the East
Asian/Beijingmay have only recently arrived inMalawi compared to other
Mycobacterium tuberculosis lineages [8]. The spread of L2/Beijing inMalawi
could also be attributed to recent inﬂux of people of Eastern-Asian ethnic
background involved in road construction and trade. Additionally, there
has been an increase of Malawian business people travelling to China over
the past few years. A country-wide study on the diversity of L2/Beijing
strain in Malawi will be needed to fully conﬁrm the current prevalence of
this lineage and its drug sensitivity proﬁle and to monitor trends in its
representation among cases of tuberculosis in Malawi in the future. In this
study we have demonstrated concordance in lineage assignment of strains
using LSP-PCR, SNP analysis and DNA methylation analysis. We have
shown that the circulating Mtb strains in Blantyre, southern Malawi, are
broadly similar to those previously described in northernMalawi [13]. The
L2 and drug resistance remain rare in both locations, with Euro-American
(L4) strains predominating. The increasing bidirectional economic
migration between Malawi and China, may lead to changes in the mo-
lecular epidemiology of Mtb in Malawi over the coming decade and this
study provides a ﬁrst baseline insight into the current pattern of circulating
Mtb strains. Overall the assay used in this study did not detect any mixed
infections. Presence of mixed infections would have meant over-
representation of certain strains thereby given different results. A more
robust method such as SNP typing or spoligotyping would be required to
give a greater insight of the circulating strains in Blantyre.
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